San Diego, CA, USA – December 18, 2014 – HUYA Bioscience International, a leader in accelerating the global development of China’s pharmaceutical innovations, today announced a strategic collaboration agreement with China Wuqing Development Area, a state-level economic and technological development area located between Beijing and Tianjin. The collaboration will focus on promoting biomedical innovations from companies located in the Area. Continue reading →

San Diego, CA, USA – September 15, 2014 – HUYA Bioscience International (HUYA), a leader in accelerating the global development of China’s pharmaceutical innovations, today announced a joint venture with Tianjin Institute of Pharmaceutical Research (TIPR) to develop medical technologies and therapies, originating in both China and the western world, for global markets. Continue reading →

San Diego, CA, USA – August 18, 2014 — HUYA Bioscience International, a leader in accelerating the global development of China’s pharmaceutical innovations, today announced a strategic partnership with the Changzhou Center for Biotech Development (CZCBD). This partnership will focus on advancing the worldwide potential of innovations from bio-pharmaceutical companies located in Changzhou that could meet critical global pharmaceutical pipeline needs. Continue reading →

San Diego, CA, USA – March 6, 2013 — HUYA Bioscience International announced today a collaborative partnership with Shanghai Zhangjiang Biotech and Pharmaceutical Base Development Co., Ltd. and Shanghai Pharma Engine Co. Ltd. (collectively, “Zhangjiang Biotech Pharmaceutical Base”). HUYA is an international leader in accelerating the global development of China’s pharmaceutical innovations. This new partnership will focus on innovations coming out of companies located in Zhangjiang Biotech Pharmaceutical Base that could meet critical global pharmaceutical pipeline needs. Continue reading →

San Diego, CA, USA – August 20, 2012 — HUYA Bioscience International announced today a strategic partnership with one of China’s leading research organizations, Tianjin Research Center of Basic Medical Sciences (TJRCBMS). HUYA is an international leader in accelerating the global development of China’s pharmaceutical innovations. Their new partnership with TJRCBMS will focus on innovations coming out of this newly formed institution that could meet critical global pharmaceutical pipeline needs. Continue reading →

San Diego, CA, USA – March 20, 2012 — HUYA Bioscience International announced today a critical strategic partnership with one of China’s preeminent pharmacological researchers, Prof. Deyong Ye of Fudan University’s School of Pharmacy. HUYA is an international leader in supporting the global development of China’s pharmaceutical innovations. Their new partnership with Fudan University will focus on specific innovations coming out of Prof. Deyong Ye’s lab that could meet critical global pharmaceutical needs. Continue reading →

San Diego, CA, USA – January 18, 2012 — HUYA Bioscience International today announced a strategic partnership agreement with the Tianjin Institute of Pharmaceutical Research (TIPR). HUYA is a leader in globalizing China’s biopharmaceutical innovations and TIPR is one of the leading pharmaceutical research institutes in China. The collaborative agreement will combine both parties‘ strengths in promoting the advancement of China’s drug innovations. Continue reading →

San Diego, CA, USA – November 8, 2011 — HUYA Bioscience International, a leader in globalizing China’s pharmaceutical innovations, today announced a strategic partnership with the Shenzhen Polytechnic School of Applied Chemistry and Biotechnology (SPSACBT). The alliance with HUYA will assist the school in accelerating the development of novel drugs, discovered from research laboratories within the school, to international standards. Continue reading →

San Diego, CA, USA – October 18, 2011 — HUYA Bioscience International, a leader in globalizing China’s biopharmaceutical innovations, today announced a strategic alliance with the Tianjin International Joint Academy of Biotechnology and Medicine (TJAB). The alliance will unite the strength and resources of both parties to accelerate the development of China’s biomedical innovation and industrialization. Continue reading →

San Diego, CA, USA – September 8, 2011 — HUYA Bioscience International, a leader in globalizing China’s pharmaceutical innovations, today announced a strategic partnership with the Zhejiang Chinese Medical University Life Science College. The collaboration agreement will accelerate the global drug development of China’s novel Traditional Chinese Medicines (TCM). Continue reading →